Literature DB >> 8310818

Alz-50 and ubiquitin immunoreactivity is induced by permanent focal cerebral ischaemia in the cat.

D Dewar1, D I Graham, G M Teasdale, J McCulloch.   

Abstract

The effects of permanent focal cerebral ischaemia on Alz-50 and ubiquitin antibody immunohistochemical staining were investigated in vivo in the cat. Alz-50 and ubiquitin antibody staining was compared to the distribution of ischaemic cell damage. Six hours following permanent occlusion of one middle cerebral artery, Alz-50 immunoreactivity was present in neurones in the ipsilateral ischaemic cerebral cortex and caudate nucleus but not in any region of the contralateral hemisphere or in sham-operated cats. Only a proportion of neurones were stained with Alz-50 and these did not have the shrunken, pyknotic appearance characteristic of irreversible ischaemic cell damage. Ubiquitin immunoreactivity was also increased in the ischaemic hemisphere, again only a proportion of neurones were stained. The Alz-50 antibody recognises the microtubule-associated protein tau and stains neurofibrillary tangles as well as neurones vulnerable to neurofibrillary change in tissue sections of Alzheimer brain. The results indicate that there are changes in tau protein in response to an ischaemic insult, but only in some neurones, which may reflect an early stage of the degenerative process. Increased ubiquitin immunoreactivity may be a response to the presence of abnormal proteins, including tau, which are induced by an ischaemic challenge.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8310818     DOI: 10.1007/bf00294302

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  48 in total

1.  Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF.

Authors:  B Cheng; M P Mattson
Journal:  Exp Neurol       Date:  1992-08       Impact factor: 5.330

Review 2.  Rodent models of cerebral ischemia.

Authors:  M D Ginsberg; R Busto
Journal:  Stroke       Date:  1989-12       Impact factor: 7.914

3.  Mapping of the Alz 50 epitope in microtubule-associated proteins tau.

Authors:  H Ksiezak-Reding; C H Chien; V M Lee; S H Yen
Journal:  J Neurosci Res       Date:  1990-03       Impact factor: 4.164

4.  Induced tolerance to ischemia in gerbil hippocampal neurons.

Authors:  T Kirino; Y Tsujita; A Tamura
Journal:  J Cereb Blood Flow Metab       Date:  1991-03       Impact factor: 6.200

5.  Phosphorylation affects the ability of tau protein to promote microtubule assembly.

Authors:  G Lindwall; R D Cole
Journal:  J Biol Chem       Date:  1984-04-25       Impact factor: 5.157

6.  Alz 50, a monoclonal antibody to Alzheimer's disease antigen, cross-reacts with tau proteins from bovine and normal human brain.

Authors:  H Ksiezak-Reding; P Davies; S H Yen
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

7.  Localization of 70-kDa stress protein induction in gerbil brain after ischemia.

Authors:  K Vass; W J Welch; T S Nowak
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

8.  Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated.

Authors:  D P Hanger; J P Brion; J M Gallo; N J Cairns; P J Luthert; B H Anderton
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

9.  Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.

Authors:  D W Dickson; H Crystal; L A Mattiace; Y Kress; A Schwagerl; H Ksiezak-Reding; P Davies; S H Yen
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

10.  Phosphorylation of microtubule-associated protein tau: identification of the site for Ca2(+)-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles.

Authors:  B Steiner; E M Mandelkow; J Biernat; N Gustke; H E Meyer; B Schmidt; G Mieskes; H D Söling; D Drechsel; M W Kirschner; M Goedert; E Mandelkow
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

View more
  15 in total

1.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.

Authors:  K Spittaels; C Van den Haute; J Van Dorpe; K Bruynseels; K Vandezande; I Laenen; H Geerts; M Mercken; R Sciot; A Van Lommel; R Loos; F Van Leuven
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Expression of ubiquitin-like immunoreactivity in axons after compression trauma to rat spinal cord.

Authors:  G L Li; M Farooque
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

3.  Ubiquitin-mediated stress response in a rat model of brain transient ischemia/hypoxia.

Authors:  P Gubellini; G M Bisso; A Ciofi-Luzzatto; S Fortuna; P Lorenzini; H Michalek; G Scarsella
Journal:  Neurochem Res       Date:  1997-01       Impact factor: 3.996

4.  Alzheimer's disease-type neurofibrillary degeneration in verrucose dysplasias of the cerebral cortex.

Authors:  M A Morán; A Probst; C Navarro; P Gómez-Ramos
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

5.  The potential for estrogens in preventing Alzheimer's disease and vascular dementia.

Authors:  James W Simpkins; Evelyn Perez; Xiaofei Wang; Shaohua Yang; Yi Wen; Meharvan Singh
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

6.  Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients.

Authors:  James W Simpkins; Joshua W Gatson; Jane G Wigginton
Journal:  Alzheimers Dement       Date:  2009-03       Impact factor: 21.566

Review 7.  Participation of Amyloid and Tau Protein in Neuronal Death and Neurodegeneration after Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2020-06-28       Impact factor: 5.923

Review 8.  Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.

Authors:  Ryszard Pluta; Mirosław Jabłoński; Marzena Ułamek-Kozioł; Janusz Kocki; Judyta Brzozowska; Sławomir Januszewski; Wanda Furmaga-Jabłońska; Anna Bogucka-Kocka; Ryszard Maciejewski; Stanisław J Czuczwar
Journal:  Mol Neurobiol       Date:  2013-03-22       Impact factor: 5.590

Review 9.  Tau Protein Dysfunction after Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 10.  Shared Genomic and Proteomic Contribution of Amyloid and Tau Protein Characteristic of Alzheimer's Disease to Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.